Michael Schreiber

861 total citations
41 papers, 679 citations indexed

About

Michael Schreiber is a scholar working on Virology, Infectious Diseases and Immunology. According to data from OpenAlex, Michael Schreiber has authored 41 papers receiving a total of 679 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Virology, 17 papers in Infectious Diseases and 16 papers in Immunology. Recurrent topics in Michael Schreiber's work include HIV Research and Treatment (21 papers), Mosquito-borne diseases and control (11 papers) and Immune Cell Function and Interaction (7 papers). Michael Schreiber is often cited by papers focused on HIV Research and Treatment (21 papers), Mosquito-borne diseases and control (11 papers) and Immune Cell Function and Interaction (7 papers). Michael Schreiber collaborates with scholars based in Germany, Cambodia and France. Michael Schreiber's co-authors include Herbert Schmitz, Matthias T. Dittmar, F. Hufert, Gregor Fels, Alfred Maelicke, Dorotheé von Laer, Paul Rácz, Jörn E. Schmitz, Harold H. Schmitz and Jürgen Knobloch and has published in prestigious journals such as The Lancet, Journal of Biological Chemistry and PLoS ONE.

In The Last Decade

Michael Schreiber

39 papers receiving 654 citations

Peers

Michael Schreiber
Brian D. Hansen United States
Siyuan Shen United States
Lisa A. Ware United States
Jonathan M. Wagner United States
Sydney Stanley United States
Catherine Jett United States
Brian D. Hansen United States
Michael Schreiber
Citations per year, relative to Michael Schreiber Michael Schreiber (= 1×) peers Brian D. Hansen

Countries citing papers authored by Michael Schreiber

Since Specialization
Citations

This map shows the geographic impact of Michael Schreiber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Schreiber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Schreiber more than expected).

Fields of papers citing papers by Michael Schreiber

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Schreiber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Schreiber. The network helps show where Michael Schreiber may publish in the future.

Co-authorship network of co-authors of Michael Schreiber

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Schreiber. A scholar is included among the top collaborators of Michael Schreiber based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Schreiber. Michael Schreiber is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Beier, Sebastian, et al.. (2023). Isolation of Cells from Glioblastoma Multiforme Grade 4 Tumors for Infection with Zika Virus prME and ME Pseudotyped HIV-1. International Journal of Molecular Sciences. 24(5). 4467–4467. 4 indexed citations
3.
Schreiber, Michael, et al.. (2015). Effect of Lysine to Arginine Mutagenesis in the V3 Loop of HIV-1 gp120 on Viral Entry Efficiency and Neutralization. PLoS ONE. 10(3). e0119879–e0119879. 7 indexed citations
4.
Häuser, H., et al.. (2014). A virus–envelope paired competitive assay to study entry efficiency of human immunodeficiency virus type 1 in vitro. Journal of Virological Methods. 205. 91–98. 3 indexed citations
5.
Eggers, Christian, et al.. (2013). Genetic shift of env V3 loop viral sequences in patients with HIV-associated neurocognitive disorder during antiretroviral therapy. Journal of NeuroVirology. 19(6). 523–530. 3 indexed citations
6.
Schaal, Heiner, et al.. (2010). Neutralization of X4- and R5-tropic HIV-1 NL4-3 variants by HOCl-modified serum albumins. BMC Research Notes. 3(1). 155–155. 7 indexed citations
7.
Schreiber, Michael, et al.. (2009). Effects of mutations on HIV‐1 infectivity and neutralization involving the conserved NNNT amino acid sequence in the gp120 V3 loop. FEBS Letters. 583(7). 1201–1206. 6 indexed citations
8.
Schreiber, Michael, et al.. (2008). West Nile virus is neutralized by HOCl-modified human serum albumin that binds to domain III of the viral envelope protein E. Virology. 373(2). 322–328. 8 indexed citations
9.
Huskens, Dana, Katrien Princen, Michael Schreiber, & Dominique Schols. (2007). The role of N-glycosylation sites on the CXCR4 receptor for CXCL-12 binding and signaling and X4 HIV-1 viral infectivity. Virology. 363(2). 280–287. 23 indexed citations
10.
Schreiber, Michael, et al.. (2006). N-Glycans in the gp120 V1/V2 domain of the HIV-1 strain NL4-3 are indispensable for viral infectivity and resistance against antibody neutralization. Medical Microbiology and Immunology. 195(3). 165–172. 44 indexed citations
12.
Dittmar, Matthias T., et al.. (2001). Loss of N-linked glycans in the V3-loop region of gp120 is correlated to an enhanced infectivity of HIV-1. Glycobiology. 11(1). 11–19. 53 indexed citations
13.
Schäfer, Andreas, et al.. (1998). Synthesis of an N-glucoasparagine analog as a building block for a V3-loop glycopeptide from GP120 of HIV-I. Carbohydrate Research. 313(2). 107–116. 5 indexed citations
14.
Müller, Thomas, et al.. (1998). The muskrat (Ondatra zibethicus) as a new reservoir for puumala-like hantavirus strains in Europe. Virus Research. 57(2). 139–150. 5 indexed citations
15.
Schreiber, Michael, et al.. (1996). Loss of antibody reactivity directed against the V3 domain of certain human immunodeficiency virus type 1 variants during disease progression. Journal of General Virology. 77(10). 2403–2414. 14 indexed citations
16.
Tennstedt, C., et al.. (1994). [Pathological-anatomical findings after serologic and molecular biologic evidence of Hantaan virus infection].. PubMed. 140(2). 173–80. 2 indexed citations
17.
Shahabuddin, Mohammed, Kathrin Günther, Klaus Lingelbach, et al.. (1992). Localisation of hypoxanthine phosphoribosyl transferase in the malaria parasite Plasmodium falciparum. Experimental Parasitology. 74(1). 11–19. 17 indexed citations
18.
Kun, Jürgen F. J., Josef Hesselbach, Michael Schreiber, et al.. (1991). Cloning and expression of genomic DNA sequences coding for putative erythrocyte membrane-associated antigens of Plasmodium falciparum. Research in Immunology. 142(3). 199–210. 32 indexed citations
19.
Knobloch, Jürgen & Michael Schreiber. (1990). Bb65, a Major Immunoreactive Protein of Bartonella Bacilliformis. American Journal of Tropical Medicine and Hygiene. 43(4). 373–379. 17 indexed citations
20.
Maelicke, Alfred, et al.. (1988). Antibodies as Probes of the Structure and Function of the Nicotinic Acetylcholine Receptor. Journal of Receptor Research. 8(1-4). 133–142. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026